394 related articles for article (PubMed ID: 26874258)
21. A comparison between cisatracurium and rocuronium-induced neuromuscular block on laryngeal electromyography recovery after neostigmine reversal in a porcine model.
Lu IC; Tan H; Wu SH; Huang TY; Tseng HY; Wang JJ; Dionigi G; Chai YJ; Chiang FY; Chang PY; Wu CW
Front Endocrinol (Lausanne); 2022; 13():875597. PubMed ID: 36004347
[TBL] [Abstract][Full Text] [Related]
22. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
[TBL] [Abstract][Full Text] [Related]
24. Postoperative residual curarization with cisatracurium and rocuronium infusions.
Cammu G; de Baerdemaeker L; den Blauwen N; de Mey JC; Struys M; Mortier E
Eur J Anaesthesiol; 2002 Feb; 19(2):129-34. PubMed ID: 11999596
[TBL] [Abstract][Full Text] [Related]
25. Calabadion: A new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents.
Hoffmann U; Grosse-Sundrup M; Eikermann-Haerter K; Zaremba S; Ayata C; Zhang B; Ma D; Isaacs L; Eikermann M
Anesthesiology; 2013 Aug; 119(2):317-25. PubMed ID: 23549405
[TBL] [Abstract][Full Text] [Related]
26. Delayed reversal of a potentiated rocuronium neuromuscular block.
Dubois PE
Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
[No Abstract] [Full Text] [Related]
27. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
[TBL] [Abstract][Full Text] [Related]
28. Duration of neuromuscular block is more variable and recovery time is shorter with rocuronium than cisatracurium in anesthetized dogs.
Martin-Flores M; Hackman MC; Araos JD; Campoy L; Gleed RD
Vet Ophthalmol; 2023 Sep; 26(5):407-413. PubMed ID: 36799561
[TBL] [Abstract][Full Text] [Related]
29. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
[TBL] [Abstract][Full Text] [Related]
30. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
31. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia.
Amin AM; Mohammad MY; Ibrahim MF
Middle East J Anaesthesiol; 2009 Feb; 20(1):39-51. PubMed ID: 19266825
[TBL] [Abstract][Full Text] [Related]
33. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
Aouad MT; Alfahel WS; Kaddoum RN; Siddik-Sayyid SM
BMC Anesthesiol; 2017 Apr; 17(1):57. PubMed ID: 28399799
[TBL] [Abstract][Full Text] [Related]
34. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
35. Cisatracurium vs. Rocuronium: A prospective, comparative, randomized study in adult patients under total intravenous anaesthesia.
Adamus M; Belohlavek R; Koutna J; Vujcikova M; Janaskova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):333-8. PubMed ID: 17426802
[TBL] [Abstract][Full Text] [Related]
36. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
Ammar AS; Mahmoud KM; Kasemy ZA
Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
[TBL] [Abstract][Full Text] [Related]
37. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
[TBL] [Abstract][Full Text] [Related]
38. Under sevoflurane anaesthesia, a reduced dose of neostigmine can antagonize a shallow neuromuscular block: A double-blind, randomised study.
Preault A; Capron F; Chantereau C; Donati F; Dimet J
Anaesth Crit Care Pain Med; 2016 Aug; 35(4):269-73. PubMed ID: 27131419
[TBL] [Abstract][Full Text] [Related]
39. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
Fuchs-Buder T; Baumann C; De Guis J; Guerci P; Meistelman C
Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
[TBL] [Abstract][Full Text] [Related]
40. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
